Immunotherapy News - Latest Updates & Headlines
New antibody reduces tumor growth in treatment-resistant breast, ovarian cancers: Study
London, March 16: Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being studied as an alternative to chemotherapy and radiotherapy. This is because it directly targets cancer cells, reducing the negative effects associated with more conventional treatments.
Scientists focus on a new antibody to fight treatment-resistant cancers
New Delhi, March 13: A team of scientists is investigating a new type of antibody, which stimulates the immune system to target cancer cells and slows tumour growth in treatment-resistant breast and ovarian cancers.
Combination immunotherapy may cure patients with deadly advanced skin cancer
New Delhi, Feb 18: A combination immunotherapy may help cure a majority of patients with melanoma -- a deadly skin cancer -- that has spread to the brain, revealed a seven-year follow-up results from a clinical trial on Tuesday.
Australian research offers new treatment hope for deadly childhood cancers
Sydney, Feb 12: Australian researchers have developed a new treatment for deadly childhood cancer using engineered immune cells.
New research identified rare type immune cells for response against Cancer: Study
Melbourne, February 3: The researchers have identified a rare type of immune cell, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses against cancer and other chronic infections.
Research unlocks key to long-lasting immune response in cancer
Melbourne, February 1: Prolonged illnesses, such as cancer and persistent infections, can fatigue the immune system, causing its frontline defenders, T cells, to lose their ability to act efficiently.
Immune cells found to boost cancer treatment in acute myeloid leukemia: Study
New York, January 25: A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics achieved a significant finding in cancer immunotherapy.
Safdarjung Hospital performs its first-ever (CAR) T-cell therapy to treat certain types of lymphoma and blood cancers
New Delhi, January 24: The VMMC and Safdarjung Hospital has successfully performed its first-ever Chimeric Antigen Receptor (CAR) T-cell therapy under the leadership of Prof. Sandeep Bansal (Medical Superintendent), a novel treatment for certain types of lymphoma and blood cancers.
Australian research makes breakthrough in boosting breast cancer cure rate
Sydney, Jan 23: Australian researchers have made a breakthrough in improving the cure rate for the most common form of breast cancer.